Arrhythmogenic Right Ventricular Cardiomyopathy Clinical Trial
Official title:
Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV9 used for gene therapy in a population of patients with PKP2 gene-associated ARVC. Participation from all patients is encouraged regardless of interest in or eligibility for gene therapy.
Patients will receive standard of care treatments and assessments under the care of their healthcare provider. Biologic samples will be collected annually to measure cardiac and other related biomarkers. Clinical and observational data will be collected prospectively for up to 5 years from the date of enrollment, or until the patient withdraws consent/assent, undergoes heart transplantation, or dies. If consent is provided, there may be a one-time sample collection to evaluate genetics for research purposes. Quality of Life (QoL) questionnaires will be used to assess a patient's wellbeing and quality of life. If not included as part of a patient's standard of care, diagnostic Holter (or equivalent) monitoring will be required annually. No investigational product will be administered. Participation from all patients is encouraged regardless of interest in or eligibility for gene therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03177018 -
DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|
N/A | |
| Recruiting |
NCT05799833 -
Low QRS Voltages in Young Healthy Individuals and Athletes
|
||
| Recruiting |
NCT03061994 -
Metabolomic Study of All-age Cardiomyopathy
|
N/A | |
| Completed |
NCT00292032 -
Registry of Unexplained Cardiac Arrest
|
||
| Completed |
NCT04124237 -
Long Term Monitoring for Risk of Sudden Death
|
||
| Recruiting |
NCT06228924 -
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
|
Phase 1 | |
| Enrolling by invitation |
NCT03527342 -
Sahlgrenska Cardiomyopathy Project
|
||
| Completed |
NCT03685149 -
Pilot Randomized Trial With Flecainide in ARVC Patients
|
Phase 2 | |
| Recruiting |
NCT03076580 -
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
|
||
| Completed |
NCT02302274 -
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
|
||
| Recruiting |
NCT03572569 -
Risk Stratification in Children and Adolescents With Primary Cardiomyopathy
|
||
| Completed |
NCT01804699 -
National ARVC Data Registry and Bio Bank
|
||
| Recruiting |
NCT05024708 -
Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)
|
N/A | |
| Recruiting |
NCT03049254 -
Mayo AVC Registry and Biobank
|
||
| Recruiting |
NCT02989480 -
PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC
|
||
| Completed |
NCT02291393 -
The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
|
N/A | |
| Recruiting |
NCT04265040 -
DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
|
||
| Recruiting |
NCT06040242 -
Arrhythmogenic Activity During Exercise in ARVC Patients
|
N/A | |
| Recruiting |
NCT02432092 -
Pediatric Cardiomyopathy Mutation Analysis
|
||
| Active, not recruiting |
NCT04895540 -
South Asian Arrhythmogenic Cardiomyopathy Registry
|